An Overview Of Recombinant Vaccines Against Viral, Fungal, Bacterial And Parasitic Diseases
- سال انتشار: 1403
- محل انتشار: هشتمین کنفرانس بین المللی یافته های نوین در علوم پزشکی و بهداشت با رویکرد ارتقای سلامت
- کد COI اختصاصی: MSHCONG08_041
- زبان مقاله: انگلیسی
- تعداد مشاهده: 190
نویسندگان
Department of Microbiology.Faculty of Biological Sciences. Falavarjan Branch Islamic Azad University. Isfahan.Iran.
Department of Microbiology.Faculty of Biological Sciences. Falavarjan Branch Islamic Azad University. Isfahan.Iran
Department of Microbiology.Faculty of Biological Sciences. Falavarjan Branch Islamic Azad University. Isfahan.Iran
Department of Microbiology.Faculty of Biological Sciences. Falavarjan Branch Islamic Azad University. Isfahan.Iran
Department of Microbiology.Faculty of Biological Sciences. Falavarjan Branch Islamic Azad University. Isfahan.Iran
چکیده
In the present era, particularly with the outbreak of infectious diseases including viral, fungal, parasitic, and bacterial infections, the need for designing and producing vaccines has become more critical than ever. Vaccination is one of the greatest public health achievements of the past century, protecting and improving the quality of life for people worldwide. Recombinant vaccines, produced using recombinant DNA technology, are discussed in this study. The microorganisms causing infections in humans, birds, and animals include adenovirus, infectious laryngotracheitis virus, human papillomavirus, Brucella and Listeria, Candida, Aspergillus, Cryptococcus, and Listeria. Vaccination is a highly effective strategy for controlling these types of diseases, making the acceleration of vaccine development essential for combating these diseases. Since one of the main factors contributing to the increased frequency and severity of diseases is the lack of cellular or humoral immunity, vaccine strategies must be safe and effective in hosts with both healthy and compromised immune systems. Advances in proteomics and systems biology have facilitated the development of several proposed vaccines, particularly as these vaccines enable the localization of proteins and the description of their changes, functions, and interactions.کلیدواژه ها
Infectious diseases, Listeria, Candida, Adenovirus, Leishmania, Recombinant vaccine, Disease controlمقالات مرتبط جدید
- Lactic Acid Bacteria Probiotics in The Prevention of Gestational Diabetes: Mechanistic Insights and Potential Long-Term Cancer Risk Reduction
- وضعیت تغذیه و عادات غذایی در بیماران مبتلا به سندرم خوردن شبانه
- The Role of Holistic Pharmacy in Cancer Patient Care
- Oral Health, Periodontal Disease, Oral Microbiome and Stroke Risk: Mechanisms and Translational Potential
- نقش مداخلات تغذیه ای مبتنی بر پروبیوتیک ها و پری بیوتیک ها در بهبود سلامت روده و پیشگیری از بیماری های متابولیک
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.